CSI Market
Sign In | Register

Mangoceuticals Inc (MGRX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MGRX quarterly Cash Flow →
The quarterly cash flow data below helps track how Mangoceuticals Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023)
Operating Activities
Income-20.64
Depreciation & amortization0.00
Amortization of Other Assets1.12
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation11.88
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.02
Issuance Of Common Stock For Services-
Imputed Interest Expense-
Options Vested For Stockbased Compensation-
Increase Decrease In Operating Lease Right Of Use Asset0.07
Increase Decrease In Investment In Subsidiary-
Interest Expense-
Amortization Of Discount On Preferred Stock-
Issuance Of Series C Convertible Preferred For Patent Acquisition-
Reverse Stock Split Rounding Adjustment-
Increase Decrease In Operating Lease Liability-0.07
Increase Decrease In Other Liabilities Related Parties-
Income taxes0.01
Losses/ -gains on Investments net0.00
Increase (Decrease) in Due from Related Parties-0.02
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.06
Accrued Expense0.00
Increase (Decrease) in Security Deposits-0.02
Increase (Decrease) in Prepaid Expense1.24
Other Working Capital-0.22
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.72
Discontinued operations0.00
Net Cash flow from Operating Activities-5.85
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.47
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.55
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.10
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Warrant Exercises One-
Proceeds From Collection Of Subscriptions Receivable1.15
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.27
Effect of exchange rate on cash flow0.01
Discontinued operations0.00
Free Cash Flow-5.85
Total Cash Flow1.42
4 historic quarters locked

Sign in to unlock the full Mangoceuticals Inc cash flow history.

Sign In Create Free Account

About Mangoceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 1, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-014478

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License